How Inclusive Pharmacogenomics Improves Care for Every Patient
Effectiveness and safety of drug treatments varies significantly from one individual to another. Adjusting prescriptions to account for these differences has often required trial-and-error, placing the patient at risk for an adverse drug reactions (ADRs) or ineffective treatment. Scientific breakthroughs in the field of Pharmacogenomics (PGx) have uncovered the associations between individual’s genetic profiles and response to certain drugs.
Leveraging our scientific team’s 20+ years of genomics research and scientific breakthroughs, RPRD develops and offers inclusive PGx testing, to enable personalize therapies, improving clinical outcomes for every patient across all races and ethnicities.